Alemtuzumab-Induced Autoimmune Thyroid Dysfunction

Alemtuzumab, a humanized monoclonal antibody used as a disease-modifying treatment in relapsing-remitting multiple sclerosis (RRMS), frequently causes autoimmunity as its principal adverse effect. We describe a typical case of a young man treated with two courses of alemtuzumab presenting 18 months...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragavan, Sharanniyan, Elhelw, Omar, Majeed, Waseem, Kyriacou, Angelos, Syed, Akheel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971069/
https://www.ncbi.nlm.nih.gov/pubmed/35371892
http://dx.doi.org/10.7759/cureus.22751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971069/
https://www.ncbi.nlm.nih.gov/pubmed/35371892
http://dx.doi.org/10.7759/cureus.22751

Ejemplares similares